# Study of a Single Dose of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects

> **NCT03384290** · PHASE1 · COMPLETED · sponsor: **Pieris Australia Pty Ltd** · enrollment: 72 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** PRS-060
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03384290
- **Lead sponsor:** Pieris Australia Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-08
- **Primary completion:** 2018-10-11
- **Final completion:** 2018-10-11
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2020-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03384290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03384290, "Study of a Single Dose of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03384290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*